Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
The current Johnson & Johnson(JNJ) stock price is $265.56, with a market capitalization of 639.97B. The stock trades at a price-to-earnings (P/E) ratio of 30.87 and offers a dividend yield of 1.98%.
During the trading session on 2026-09-15, Johnson & Johnson(JNJ) shares reached a daily high of $266.24 and a low of $260.68. At a current price of $265.56, the stock is +1.9% higher than the low and still -0.3% under the high.
Trading volume for Johnson & Johnson(JNJ) stock has reached 2.52M, versus its average volume of 6.07M.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $281.07 and a low of $173.33.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $281.07 and a low of $173.33.
JNJ News
...
The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnso...
Johnson & Johnson (NYSE:JNJ) on Monday announced new clinical results from its Phase 2b COPERNICUS study evaluating subcutaneous RYBREVANT FASPRO combined with...
Analyst ratings
70%
of 27 ratingsMore JNJ News
A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #10 broker pick, on average, out of the 30 stocks m...
In early trading on Tuesday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up...
Guggenheim assumed coverage of Nanobiotix (NBTX) with a Buy rating and $64 price target. The firm’s investment thesis is centered on the company’s first-in-clas...
Johnson & Johnson announced new results from the Phase 2b COPERNICUS study evaluating how subcutaneous Rybrevant Faspro plus Lazcluze, with less frequent dosing...
In a report released yesterday, Michael Nedelcovych from TD Cowen maintained a Buy rating on Johnson & Johnson, with a price target of $300.00. Michael Nedelco...
The company states: “Contineum (CTNM) Therapeutics announced that the MOONLIGHT-1 trial did not achieve its primary efficacy endpoint. The trial evaluated impro...
Johnson & Johnson (NYSE:JNJ) executives said the company remains on track to grow through biosimilar competition for STELARA and expects its portfolio of medici...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.